Friday, July 20, 2018
Company News: Page (1) of 1 - 01/04/18 Email this story to a friend. email article Print this page (Article printing at page facebook
Laura Luck Martinez Appointed Executive Vice President of OmniSure Consulting Group
(January 04, 2018)
Laura Luck Martinez Appointed Executive Vice President of OmniSure Consulting Group

OmniSure Consulting Group (, a nationwide leader in clinical risk management and patient safety, has announced Laura Luck Martinez, BSN, RN, MS, CPHRM, FASHRM, has assumed the position of executive vice president. Martinez has worked in healthcare risk management since 1995, starting at Zurich American and holding progressive risk management and patient safety positions with Chubb; Darwin; Allied World and Mag Mutual, where she led the development and implementation of patient safety, quality and risk mitigation programs and resources for hospitals, healthcare facilities, senior care organizations and physician practices.

As executive vice president of OmniSure, Martinez will assume responsibility for directing the organization's growth, while ensuring profitable operations and maintaining OmniSure's unique culture and commitment to its clients.

“I am honored and excited to join the OmniSure team," Martinez said. “The commitment of everyone in this company to patient and resident safety, client service and the kind of return on investment that leads to lasting relationships is what makes OmniSure special. Our innovative approach and our nationwide network of highly specialized consultants have been the foundation of OmniSure's success. I look forward to working with our professional liability insurance partners, our affiliated associations and the healthcare professionals they serve and the amazing OmniSure team to achieve future goals and write the next chapter in a nearly 18-year history."

A registered nurse, Martinez holds multiple licenses and certifications in nursing and risk management and is an active member of the American Society for Healthcare Risk Management (ASHRM) as well as a frequent speaker at industry trade conferences. For ASHRM, she's served on the Conference Planning Committee, the Ethics Committee, the 2030 Fund, the Chapters Leaders Task Force and the New Member Task Force.

“Laura is a perfect fit to lead OmniSure's new business and product development," said Michelle Foster Earle, president and founder of OmniSure. “I am excited about the possibilities that lie ahead for OmniSure and its stakeholders and look forward to working with Laura and the rest of the team as we stay committed to delivering outstanding service to our partners and clients."

About OmniSure Consulting Group
OmniSure provides risk management consulting for healthcare, senior care, human services and design professionals. It is contracted by insurance carriers, risk retention groups, brokers and self-insured entities to provide best practice assessments; clinical, regulatory, and risk consultations; educational programs; advice-on-demand and other support needed through a nationwide network of consultants. For more information, please visit

                                                                                             # # #

Read the full story at

Page: 1

Related Keywords:
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter

  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Vision Care Product Market To Witness Enhanced Growth Owing To Rising Occurrence Of Eye Disorders Till 2021 | Million Insights
  • Global Prosthetic Heart Valve Market Reaching at a CAGR of +12.70% by Geography, Deployment Model, Component, and Key players are Boston Scientific Cardiology, CryoLife, Inc., Abbott
  • Trauma Fixation Global Market to Register Steady Expansion During 2018-2025
  • Global Surgical Apparel Market Will Reach USD 2,966.58 million by 2024: Zion Market Research

  • Mesothelioma is a Deadly Cancer and it’s Completely Preventable
  • HedgePath Pharmaceuticals Granted Exclusive Option to License UCONN's Patented Chemical Analogues of Itraconazole
  • Alligator Bioscience Submits Application to Start Clinical Phase I Study in Cancer Patients with ATOR-1015, a Unique CTLA-4 and OX40 Binding Antibody
  • Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia
  • Omega-3 Market to Reach US$ 16.37 Bn by 2023, Globally -

    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines